Health Care Reform

The nation's leading lobbying group for seniors filed an amicus brief on Monday in Washington, D.C., urging a federal court to dismiss a lawsuit filed by Merck to challenge Medicare's Drug Price Negotiation Program.

The benefits world has made enormous strides in this area in recent years, fueled by the efforts and intention of industry professionals and organizations.

The Chamber of Commerce urged a federal judge on Friday to stop the new Medicare drug price negotiation program before Oct. 1, when the makers of the first 10 drugs must agree to start negotiations.

The latest update focuses on competition and vertical integration. What does it mean for the PBM industry?

While Congress moves closer to pharmacy benefit manager reform with new legislation pending, "achieving large reductions in prescription drug costs" will require a different approach, says the Brookings Institution.

CMS' new Advancing All-Payer Health Equity Approaches and Development (AHEAD) Model will award states up to $12 million to shift health care spending towards primary care and community-based care.